ESMO Events 2026
Meetingsopens in new tab/window | ESMOopens in new tab/window
Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.
Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the theme of the meeting:
ESMO AI & Digital Oncology Congress 2026opens in new tab/window
The congress brings together healthcare and digital health experts from around the world, to explore research, ethical dialogue, and technological innovation in cancer care. The scientific and educational programme will explore advances in AI and digital oncology, the challenges of methodology, ethics, regulation, and clinical implementation, while bringing together perspectives across disciplines to examine what it takes to move innovation from research into practice. Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.
Annals of Oncology
A multimodal deep learning model for preoperative prediction of post-operative complications in gastric canceropens in new tab/window P.A. Ding, S. Yang, L.J. Meng, S. Chen, S.P. Li, H.H. Guo, J.X. Yang, S. Ma, Y.H. Yang, K.X. Gao, R.J. Gu, L.L. Zhang, Y.L. Chen, Y.L. Shi, H. Long, Z.J. Xia, N. Meng, X.L. Li, Z.J. Guo, X. Han, Q. Zhao
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentationopens in new tab/window R. Philips, A. Mahajan, L. Estephan, S. Auger, W. Haque, D. Palmer, J. McQueen, E. MacCracken, P.P. Argyris, A. Trzcinska, N.A. Cipriani, M. Lingen, I. Hussain, M. Muzaffar, O. Pasternak-Wise, J. Curry, R. Katipally, A. Juloori, D. Haraf, P. Heinlen, N.J. Choudhury, A. Rosenberg, E. Vokes, H. Arshad, E. Blair, N. Agrawal, S. Shah, A.T. Pearson
ESMO Open
Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric canceropens in new tab/window H.-D. Kim, S. Shin, W. Hwang, J. Shin, T. Lee, J. Hyung, J. Park, S. Pereira, C.-Y. Ock, A. Puccini, G. Carloni, Y.S. Park, M.-H. Ryu
Genomic landscape of ERBB3 alterations in metastatic solid tumours: a real-world data analysisopens in new tab/window M. Kwon, Y. Go, J.E. Shin, S.H. Lim, J.Y. Hong, S.H. Park, J.O. Park, J. Lee, S.Y. Ha, S.T. Kim
Immuno-Oncology and Technology
A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinomaopens in new tab/window O. Kilim, O. Pipek, Z. Sztupinszki, M. Diossy, A. Prosz, C. Naceur-Lombardelli, S. Veeriah, D. Moore, M. Jamal-Hanjani, A. Hackshaw, J. Fillinger, J. Moldvay, I. Csabai, C. Swanton, Z. Szallasi
ESMO Real World Data and Digital Oncology
From electronic health records to real-world evidence: Savana Next-Generation Registry digital solutionopens in new tab/window J. Marin-Corral, N. Iglesias, S. Menke, D. Casadevall, I.H. Medrano, J. Tello, A.J. Muñoz, B.E. Miller, H. Mehanna, M. Rodríguez, M. Taberna
Automatic prediction of patients early discontinuation in oncology clinical trialsopens in new tab/window L. Olgiati, Q. Filori, S. Toueress, C. Brutti-Mairesse, L. Zidane, N. Ikhlef, L. Gueguen, L. Verlingue
ESMO Rare Cancers
One registry, many values: trade-offs in building a rare cancers data infrastructureopens in new tab/window C. Egher, S. van Hees, W. Boon, A. Trama the IDEA4RC Working Group
ESMO affiliated journals
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysisopens in new tab/window Andrea Carlini, Flavia Foca, Marianna Sirico, Alberto Farolfi, Chiara Casadei, Caterina Gianni, Michela Palleschi, Nicola Gentili, Marita Mariotti, Giandomenico Di Menna, Alice Andalò, Paolo De Angelis, Olga Serra, Simone Sabbioni, Giulia Miserocchi, Daniela Montanari, Lorenzo Cecconetto, Samanta Sarti, Antonino Musolino, Filippo Merloni
Performance of large language models in ambiguous treatment scenarios of early breast canceropens in new tab/window Anton Oseledchyk, Walter Paul Weber, Benjamin Kasenda
Artificial intelligence–enabled drug discovery: A growing but largely early-stage clinical pipelineopens in new tab/window Waqas Haque, Kareena Sai-Palm, Iemaan Rana, Alessandra Esposito, Loic Verlingue, Marina Chiara Garassino, Pietro Veronesi
Artificial intelligence–based assessment of tumor bed stroma in non–small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter studyopens in new tab/window Federica Pezzuto, Luca Vedovelli, Giuseppe Maggioni, Francesco Fortarezza, Andrea Ascione, Angelina Pernazza, Daniele Marinelli, Debora Brascia, Salvatore Piscuoglio, Mariano Lombardi, Lorenzo Spaggiari, Domenico Galetta, Giulia Pasello, Marco Schiavon, Marco Anile, Andrea Dell’Amore, Dario Gregori, Paolo Graziano, Paolo Visca, Paola Bossi, Giuseppe Marulli, Elena Guerini Rocco, Giulia d’Amati, Fiorella Calabrese
Artificial Intelligence–Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer: An International Multicenter Cohort Studyopens in new tab/window Daniel Curto, Susana Hernandez, Marta Alonso, Melina Peressini, Ricardo Garcia-Lujan, Pablo Gamez, Jose Luis Campo-Cañaveral de la Cruz, Wei Sun, Shuang Han, Dongmei Lin, Christiane Kümpers, Christian Matek, Felix Elsner, Konrad Steinestel, Javier Martin-Lopez, Clara Salas, Virginia Calvo, Mariano Provencio, Luis Paz-Ares, Jon Zugazagoitia, Fernando Lopez-Rios, Esther Conde
AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myelomaopens in new tab/window Ricardo Ahrens, Behnam Yousefi, Nora Constanze Laubach, Marietta Truger, Torsten Haferlach, Sven Heins, Raphael Teipel, Constantine Mitsiades, Evangelos Papadopoulos, Kyra Ahrens, Piet Sonnemann, Maximilian Al-Bazaz, Jule Artzenroth, Lisa Leypoldt, Christoph Schaefers, Maximilian Christopeit, Moritz Kaune, Leo Rasche, Carsten Bokemeyer, Stefan Bonn, Katja Weisel, Winfried Alsdorf
Validation of a QuPath-Based Artificial Intelligence Workflow for Plasma Cell Quantification on CD138 Immunohistochemistry in an Indian Hematopathology Cohortopens in new tab/window Mohammed N. Meera, Ankur Ahuja, Venkatesan Somasundaram, Gurpreet Kaur, Parikshit Sanyal, Uday Yanamandra
ESMO's Journal Portfolio
While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.
